KIERY MCMULLEN: Open Payments
NPI 1720477649 · MESQUITE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 38 payments from 13 companies in 2025. Trend: 2023 $565 · 2024 $432 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $140 |
| Corcept Therapeutics | 3 | $113 |
| PFIZER INC. | 5 | $101 |
| Novo Nordisk Inc | 4 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $69 |
| Exact Sciences Corporation | 3 | $63 |
| Abbott Laboratories | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
Products named: JARDIANCE, Korlym, PREVNAR 20, Kerendia, Cologuard Collection Kit, FREESTYLE LIBRE 3, Ozempic, MOUNJARO.
Industry payments across TX — which companies pay providers there.
